Viva Biotech Holdings (FRA:VB0)

Viva Biotech Holdings Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 16, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	582	226	260	402	1,020	1,844
Market Cap Growth	169.24%	-13.23%	-35.25%	-60.56%	-44.70%	126.37%
Enterprise Value	614	295	490	697	1,183	1,683
Last Close Price	0.27	0.10	0.11	0.20	0.50	0.89
PE Ratio	28.43	10.21	-	-	25.63	-
PS Ratio	2.67	0.86	0.95	1.25	3.50	21.13
PB Ratio	1.25	0.45	0.55	0.82	1.88	3.92
P/TBV Ratio	3.51	1.33	1.84	3.05	6.01	10.23
P/FCF Ratio	22.85	9.32	10.43	21.69	-	-
P/OCF Ratio	13.94	4.57	5.32	7.68	94.67	341.11
EV/Sales Ratio	2.83	1.12	1.78	2.16	4.06	19.28
EV/EBITDA Ratio	11.66	5.16	9.81	11.78	23.11	81.76
EV/EBIT Ratio	22.78	9.71	19.92	19.32	36.09	119.41
EV/FCF Ratio	24.09	12.17	19.61	37.58	-	-
Debt / Equity Ratio	0.30	0.34	0.52	0.78	0.68	0.79
Debt / EBITDA Ratio	2.59	2.90	4.71	6.25	6.81	16.25
Debt / FCF Ratio	5.39	7.01	9.72	20.65	-	-
Asset Turnover	0.26	0.27	0.28	0.30	0.26	0.14
Inventory Turnover	4.24	4.88	4.84	5.61	7.33	4.53
Quick Ratio	1.22	1.26	1.03	0.44	1.44	3.75
Current Ratio	1.76	1.67	1.32	0.73	2.14	4.56
Return on Equity (ROE)	5.87%	5.92%	-2.74%	-13.41%	7.84%	-13.69%
Return on Assets (ROA)	2.03%	1.98%	1.57%	2.08%	1.83%	1.40%
Return on Invested Capital (ROIC)	4.41%	3.96%	3.74%	4.62%	4.04%	4.28%
Return on Capital Employed (ROCE)	3.90%	3.90%	3.30%	5.10%	3.30%	1.50%
Earnings Yield	3.52%	9.80%	-5.69%	-17.82%	3.90%	-2.63%
FCF Yield	4.38%	10.73%	9.59%	4.61%	-6.61%	-3.73%
Dividend Yield	-	-	-	-	-	0.33%
Payout Ratio	-	-	-	-	5.66%	-
Buyback Yield / Dilution	-48.61%	-41.39%	-5.91%	2.81%	-25.41%	-5.83%
Total Shareholder Return	-48.61%	-41.39%	-5.91%	2.81%	-25.41%	-5.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.